[Management of bronchiolitis in the infant. Recommendations. Long text]

Arch Pediatr. 2001 Jan:8 Suppl 1:11S-23S. doi: 10.1016/s0929-693x(01)80151-2.
[Article in French]
No abstract available

MeSH terms

  • Acute Disease
  • Anti-Inflammatory Agents / therapeutic use
  • Antiviral Agents / therapeutic use
  • Bronchiolitis, Viral / diagnosis*
  • Bronchiolitis, Viral / epidemiology
  • Bronchiolitis, Viral / physiopathology
  • Bronchiolitis, Viral / therapy*
  • Bronchiolitis, Viral / virology
  • Bronchodilator Agents / therapeutic use
  • Disease Progression
  • Drug Combinations
  • France / epidemiology
  • Hospitalization
  • Humans
  • Infant
  • Infant, Newborn
  • Oximetry
  • Patient Selection
  • Practice Guidelines as Topic
  • Primary Prevention / methods
  • Respiratory Therapy / methods
  • Risk Factors
  • Severity of Illness Index
  • Spironolactone
  • Sulfonamides

Substances

  • Anti-Inflammatory Agents
  • Antiviral Agents
  • Bronchodilator Agents
  • Drug Combinations
  • Sulfonamides
  • Spironolactone
  • spironolactone, althiazide drug combination